About
Skin Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
2,415
By Phase
NA: 1PHASE1: 2PHASE3: 5PHASE2: 3
By Status
COMPLETED: 11
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06628401Lead Sponsor
Comparing Approaches to Increasing Fruit and Vegetable Intake and Their Influence on Metabolic Health
NACompleted
42 participants
Started: Oct 23, 2024 · Completed: Sep 5, 2025
NCT05597462Lead Sponsor
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
PHASE1Completed
60 participants
Started: Sep 30, 2022 · Completed: May 30, 2023
NCT05452785Lead Sponsor
A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
PHASE1Completed
24 participants
Started: May 7, 2022 · Completed: May 25, 2022
NCT05343455Lead Sponsor
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
PHASE3Completed
330 participants
Started: Mar 29, 2022 · Completed: Jun 30, 2023
NCT05296629Lead Sponsor
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
PHASE3Completed
323 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2023
Locations (1)
Headquarters
Scottsdale, AZ, United States
Map
Loading map...